BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25696851)

  • 1. Therapeutic targeting of microenvironment in follicular lymphoma.
    Nowakowski GS; Ansell SM
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):169-73. PubMed ID: 25696851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory Agents in Follicular Lymphoma.
    Ysebaert L; Morschhauser F
    Hematol Oncol Clin North Am; 2020 Aug; 34(4):715-726. PubMed ID: 32586576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicular Lymphoma: The Role of the Tumor Microenvironment in Prognosis.
    Sugimoto T; Watanabe T
    J Clin Exp Hematop; 2016; 56(1):1-19. PubMed ID: 27334853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Agents Beyond Immunomodulatory Agents and Phosphoinositide-3-Kinase for Follicular Lymphoma.
    Chin CK; Nastoupil LJ
    Hematol Oncol Clin North Am; 2020 Aug; 34(4):743-756. PubMed ID: 32586578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follicular lymphoma: evolving therapeutic strategies.
    Kahl BS; Yang DT
    Blood; 2016 Apr; 127(17):2055-63. PubMed ID: 26989204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy-sparing treatment strategies for follicular lymphoma: current options and future directions.
    Ng SY; Abramson JS
    Curr Opin Hematol; 2016 Jul; 23(4):371-6. PubMed ID: 27213499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-free treatment in patients with follicular lymphoma.
    Sarkozy C; Salles G; Bachy E
    Expert Rev Hematol; 2015 Apr; 8(2):187-203. PubMed ID: 25585961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the multi-omics landscape of follicular lymphoma.
    Xu T; Zheng Z; Zhao W
    Int J Biol Sci; 2023; 19(6):1955-1967. PubMed ID: 37063433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current therapeutic strategies and new treatment paradigms for follicular lymphoma.
    Kritharis A; Sharma J; Evens AM
    Cancer Treat Res; 2015; 165():197-226. PubMed ID: 25655611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel agents for relapsed and refractory follicular lymphoma.
    Cheah CY; Fowler NH
    Best Pract Res Clin Haematol; 2018 Mar; 31(1):41-48. PubMed ID: 29452665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New agents in follicular lymphoma.
    Cheson BD
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):305-12. PubMed ID: 21658626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel agents for follicular lymphoma.
    Leonard JP; Martin P
    Hematology Am Soc Hematol Educ Program; 2010; 2010():259-64. PubMed ID: 21239803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tumor microenvironment in follicular lymphoma.
    Yang ZZ; Ansell SM
    Clin Adv Hematol Oncol; 2012 Dec; 10(12):810-8. PubMed ID: 23271353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging role of lenalidomide in the management of mantle cell lymphoma (MCL).
    Dawar R; Hernandez-Ilizaliturri F
    Best Pract Res Clin Haematol; 2012 Jun; 25(2):185-90. PubMed ID: 22687454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicular non-Hodgkin's lymphoma: correlation between histology, pathophysiology, cytogenetic, prognostic factors, treatment, survival.
    Găman AM
    Rom J Morphol Embryol; 2013; 54(1):71-6. PubMed ID: 23529311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hodgkin lymphoma: targeting the tumor microenvironment as a therapeutic strategy.
    Montanari F; Diefenbach CS
    Clin Adv Hematol Oncol; 2015 Aug; 13(8):518-24. PubMed ID: 26351815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical spectrum and prognosis of follicular lymphoma with blastoid transformation: case series and a review of the literature.
    Vaidyanathan G; Ngamphaiboon N; Hernandez-Ilizaliturri FJ
    Ann Hematol; 2011 Aug; 90(8):955-62. PubMed ID: 21286717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indolent lymphoma: follicular lymphoma and the microenvironment-insights from gene expression profiling.
    Rimsza LM; Jaramillo MC
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):163-8. PubMed ID: 25696850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving therapeutic landscape in follicular lymphoma: a look at emerging and investigational therapies.
    Hanel W; Epperla N
    J Hematol Oncol; 2021 Jun; 14(1):104. PubMed ID: 34193230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When to treat patients with relapsed follicular lymphoma.
    Cheah CY; Seymour JF
    Expert Rev Hematol; 2017 Mar; 10(3):187-191. PubMed ID: 28164722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.